- Hims & Hers Health (NYSE:HIMS) expanded its Hims & Hers Benefits program through partnerships with eight new organizations.
- The new partnerships broaden access to nutrition, fitness, women’s health, and metabolic monitoring services for subscribers.
- The company is passing these negotiated benefits to subscribers at no profit, focusing on holistic health support.
Hims & Hers Health, which started with direct to consumer prescription services across areas like hair loss, mental health, and sexual health, is increasingly positioning itself as a broader wellness platform. The expansion of Hims & Hers Benefits fits into a wider industry push toward integrated, subscription based health offerings that combine virtual care with lifestyle services.
For investors watching NYSE:HIMS, this move highlights how the company is trying to deepen subscriber relationships by tying its brand to everyday health routines rather than one off prescriptions. Over time, the way users respond to these added services could influence engagement patterns and shape how the business model develops beyond its original prescription focus.
Stay updated on the most important news stories for Hims & Hers Health by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Hims & Hers Health.
See which insiders are buying and buying and selling Hims & Hers Health following this latest news.
Quick Assessment
- ⚖️ Price vs Analyst Target: At US$25.38, Hims & Hers Health trades about 4.6% below the US$26.61 analyst price target, which is broadly in line with consensus.
- ✅ Simply Wall St Valuation: Simply Wall St estimates the stock is trading around 61.8% below its fair value, which flags a sizable valuation gap.
- ❌ Recent Momentum: The share price is down 9.1% over the last 30 days, so short term sentiment has been weak.
There is only one way to know the right time to buy, sell or hold Hims & Hers Health. Head to Simply Wall St’s
company report for the latest analysis of Hims & Hers Health’s Fair Value.
Key Considerations
- 📊 Expanding Hims & Hers Benefits without monetizing it may support the long term subscription story by deepening engagement around nutrition, fitness and women’s health.
- 📊 Watch subscriber growth, churn, and any commentary on usage of these partner services to see whether this broader wellness offering is resonating with customers.
- ⚠️ The stock carries one major risk flag for share price volatility, so short term reactions to new initiatives like this could be sharp in either direction.
Dig Deeper
For the full picture including more risks and rewards, check out the
complete Hims & Hers Health analysis. Alternatively, you can check out the
community page for Hims & Hers Health to see how other investors believe this latest news will impact the company’s narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Hims & Hers Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

